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Abstract
Aims: Real-time perfusion (RTP) adenosine stress echocardiography (ASE) can be used to visually
evaluate myocardial ischaemia. The RTP power modulation technique angio-mode (AM), provides images
for off-line perfusion quantification using Qontrast® software, generating values of peak signal intensity (A),
myocardial blood flow velocity (β) and myocardial blood flow (Axβ). By comparing rest and stress values,
their respective reserve values (A-r, β-r, Axβ-r) are generated. We evaluated myocardial ischaemia by
RTP-ASE Qontrast® quantification, compared to visual perfusion evaluation with 99mTc-tetrofosmin single-
photon emission computed tomography (SPECT).
Methods and Results: Patients admitted to SPECT underwent RTP-ASE (SONOS 5500) using AM
during Sonovue® infusion, before and throughout adenosine stress, also used for SPECT. Visual myocardial
perfusion and wall motion analysis, and Qontrast® quantification, were blindly compared to one another
and to SPECT, at different time points off-line.
We analyzed 201 coronary territories (left anterior descendent [LAD], left circumflex [LCx] and right
coronary [RCA] artery territories) in 67 patients. SPECT showed ischaemia in 18 patients and 19
territories. Receiver operator characteristics and kappa values showed significant agreement with SPECT
only for β-r and Axβ-r in all segments: area under the curve 0.678 and 0.665; P < 0.001 and < 0.01,
respectively. The closest agreements were seen in the LAD territory: kappa 0.442 for both β-r and Axβ-
r; P < 0.01. Visual evaluation of ischaemia showed good agreement with SPECT: accuracy 93%; kappa 0.67;
P < 0.001; without non-interpretable territories.
Conclusion: In this agreement study with SPECT, RTP-ASE Qontrast® quantification of myocardial
ischaemia was less accurate and less feasible than visual evaluation and needs further development to be
clinically useful.
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In low risk patients with suspected myocardial ischaemia,
evaluation of ischaemia is generally recommended for opti-
mal care and treatment [1,2]. Exercise ECG is considered the
first line technique for assessment of ischaemia, whereas sin-
gle-photon emission computed tomography (SPECT) or
dobutamine atropine stress echocardiography (DSE) are sug-
gested when exercise ECG are non-diagnostic or non-inter-
pretable [3]. Both SPECT and DSE are well established and
more accurate methods than exercise ECG [4-7], although
more expensive. Adenosine stress echocardiography (ASE)
can also be used for ischaemia evaluation, but demands eval-
uation of myocardial perfusion to reach similar accuracy for
detecting ischaemia and can not solely rely on wall motion
assessment [8,9]. The use of second generation myocardial
contrast agents enables real time myocardial perfusion (RTP)
echocardiography. RTP combined with ASE has shown
promising results in evaluating myocardial ischaemia in dif-
ferent patient populations and settings [10-18]. RTP has one
possible advantage comparing to all three mentioned tech-
niques; the ability to follow replenishment of myocardial
perfusion in real-time. Therefore, RTP has the ability to com-
pare myocardial perfusion and replenishment rate at rest and
stress, which could add valuable information and perhaps
increase the sensitivity of myocardial ischaemia detection.
One drawback is the subjectivity of visual myocardial per-
fusion evaluation by echocardiography, which demands
experienced interpreters and limits the use of RTP-ASE. Tech-
niques for objective quantification of myocardial perfusion
in echocardiography are evolving and software programs are
now commercially available. The quantitative techniques
have shown promising results in animal experiments
[19,20] and in humans [21-25]. However, there are few
studies from clinical settings and most of these have been
done with different software. If a quantitative echocardio-
graphic technique were to show equivalent results to SPECT
in detecting myocardial ischaemia, it could be an alternative
method, more available and without radiation compared to
SPECT, more tolerable and swifter than DSE, and more accu-
rate than exercise ECG.
Qontrast® (AMID®, Roma, Italy; Bracco™, Milan, Italy) is a
recently developed and commercially available software,
with algorithms that automatically follow the left myocar-
dium contours throughout the cardiac cycle and through-
out the replenishment period of the RTP image loop.
Qontrast® may provide a practical way to quantify myocar-
dial perfusion by contrast echocardiography, and has
shown promising initial results in both animals and
patients with acute myocardial infarction [20,26]. How-
ever, it has not yet been investigated in patients with sus-
pected stable myocardial ischaemia.
The aim of the present study was to examine if RTP-ASE
Qontrast® quantification can be used to correctly evaluate
myocardial ischaemia in patients with known or sus-
pected stable coronary artery disease, as compared with




We prospectively asked 69 randomly selected patients,
without prior knowledge of acoustic windows, admitted
to adenosine SPECT evaluation of known or suspected
stable coronary artery disease, to participate in the study.
Part of the study population has been presented previ-
ously [18]. Two of the included patients had visually non-
interpretable echocardiography images and were, there-
fore, excluded from the study. The institutional ethics
committee of the Lund University, Sweden, approved the




The echocardiographic equipment used was a Sonos 5500
(Philips, Andover, Massachusetts, USA) with S3 probe
and RTP using the power modulation angio-mode.
Patients were examined in a left lateral recumbent posi-
tion. The second-generation contrast agent Sonovue® was
infused in the left decubital vein using an infusion pump
dedicated for this purpose (VueJect® Esaote, Genova, Italy;
Bracco™, Milan, Italy), which automatically rotates the
syringe to prevent sedimentation. The infusion rate of
Sonovue was set between 1.0 and 1.3 ml/min [27]. Ade-
nosine and echo contrast were infused in the same periph-
eral venous catheter, using a separate infusion pump
through a three-way tap. Adenosine was given at an infu-
sion rate of 100 μg/kg/min during one minute, after
which the infusion rate was increased to 140 μg/kg/min.
All 67 patients underwent RTP imaging (mechanical
index = 0.1) during infusion of echo contrast, at rest and
after a minimum of one minute of hyperaemia during
adenosine stress (at 140 μg/kg/min). Image acquisition
was started after at least one minute of Sonovue infusion.
RTP image loops containing 8–10 heartbeats were col-
lected from the parasternal long-axis and apical four- and
two-chamber views, respectively. At the beginning of each
loop a destruction impulse of 10 high mechanical index
frames (mechanical index = 1.5) were given to destroy all
contrast micro bubbles in the myocardium [28].
During RTP the angio-mode gain was set between 60 and
70%, depending on what was suitable for the individual
patient as judged by a visual on-line assessment, and 2D
greyscale gain was set at zero. Focus was set close to the
base of the left ventricle. All images were stored digitally
for later off-line analysis.Page 2 of 10
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Qontrast® was used to produce parametric images of con-
trast replenishment values for the RTP loops collected
from both rest and stress. Two points were manually
placed in the left ventricular cavity of the perfusion
images. The first point was placed in the centre of the cav-
ity where the apex "half-circle" ends, i.e. approximately
two thirds from the base of ventricle, where it was always
inside the cavity (never in the myocardium) during the
complete loop. The point was placed in a cavity area that
was fully opacified directly after the destruction impulse
in the beginning of the loop, as well as throughout the
entire RTP-loop, since this formed the basis of the maxi-
mum image contrast intensity reference-point. Any iso-
lated frames not fulfilling these criteria were excluded
from analysis. The second point was placed at the base of
the ventricle, enabling the software to automatically out-
line the complete left ventricle, including both cavity and
myocardium, with dotted "M-mode" lines crossing per-
pendicular through the myocardial wall (Figure 1).
The first frame was selected to be the one directly after
destruction impulse frames.
Automatic perfusion analysis was then started. Qontrast®
uses an advanced image processing technique that recog-
nizes the coherence of the dynamic image sequence in a
space-time domain. The technique enables tracking of the
myocardial pixel movement throughout the cardiac cycle
and the entire RTP-loop. This increases the accuracy of the
perfusion evaluation compared to triggered imaging, due
to the higher number of quantifiable frames.
Three parametric images were then automatically gener-
ated from the perfusion analysis, displaying either the
peak signal intensity (A), myocardial blood flow velocity
(β) or myocardial blood flow (Axβ). These were generated
for each pixel, from the replenishment curve of each pixel,
according to the replenishment curve A = A(1-e-βt) [29].
These parametric images were generated from RTP images
in apical four- and two-chamber and parasternal long-axis
view, at rest and stress, respectively.
To acquire quantitative values of A, β and Axβ, region of
interests were manually traced both at rest and stress, cor-
responding to the distribution territories of the three main
coronary arteries; left anterior descending (LAD), left cir-
cumflex (LCx) and right coronary artery (RCA) (Figure 2).
Since earlier studies indicated that β is the most sensitive
quantitative parameter [24,30], special care was taken that
the tracing would align correctly in the parametric β
image, avoiding red areas. These either correspond to con-
trast in the left ventricular cavity, are due to perfusion arte-
facts originating from main coronary arteries, or are
caused by mathematically generated high β-values due to
very low A-values, which predominantly occur in rest
images where the A-values are low for physiological rea-
sons.
Comparing A, β and Axβ values at rest and stress (hyper-
aemia), the corresponding reserve values (A-r; β-r and
Axβ-r) were derived by dividing the stress value with the
matching rest value, thus resembling invasive measure-
ment of coronary flow reserve. Accordingly, this generated
three A-r, β-r, and Axβ-r values from the LAD territory,
originating from the three different echocardiographic
views (four-chamber, two-chamber, and long-axis views),
two reserve values each from the LCx territory (four-cham-
ber and long-axis views) and two from the RCA territory
(four- and two-chamber views). The lowest A-r, β-r and
Manually placed points to enable an automatic outline of the complete left ventr cle, including both cavity and myocar-diu , before automa d Qontrast® perfusion analysisFigur  1
Manually placed points to enable an automatic out-
line of the complete left ventricle, including both cav-
ity and myocardium, before automated Qontrast® 
perfusion analysis.
Tracings of coronary territories of interest in four-chamber (middle), two-chamber (left) and long-axi  (right) viewsFigur  2
Tracings of coronary territories of interest in four-
chamber (middle), two-chamber (left) and long-axis 
(right) views. LAD, left anterior descending; LCx, left cir-
cumflex; RCA, right coronary artery.Page 3 of 10
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onary territory was selected for the ischaemia comparison
with SPECT, since the lowest reserve value should origi-
nate from the most ischaemic or the least perfused terri-
tory.
RTP-ASE visual ischaemia interpretation
Two separate visual image interpretation were performed
with off-line analysis of myocardial perfusion and wall
motion at RTP-ASE, using the EnConcert Image Diagnosis
Application (Philips, Andover, Massachusetts, USA). The
first visual analysis was a combined analysis of perfusion
and wall motion. The second visual analysis, performed
separately, was an analysis excluding wall motion to esti-
mate the value of sole perfusion analysis. Visual and
quantitative perfusion analyses were done on separate
occasions, blinded to one another and blinded to the
result of SPECT. Each segment of the left ventricular myo-
cardium was attributed to the same coronary vessel terri-
tory at all analyses. Myocardial ischaemia was visually
evaluated comparing rest and stress images, using both
perfusion and wall motion analysis in a complementary
manner. A visually detected perfusion defect during stress
was used as the principal marker of ischaemia. Thus, a
myocardial segment was considered ischaemic if per-
fusion was impaired in the stress images, compared to the
rest images [8]. Perfusion defects were analyzed during
the first four beats after the destruction impulse at rest and
after two beats at peak stress. Wall motion was used in
addition to reveal perfusion defect artefacts at rest and to
evaluate segments with suspected perfusion artefacts at
stress. Since wall motion should not be normal if a seg-
ment has a true perfusion defect at rest, a perfusion defect
at rest was considered to be an artefact when wall motion
was normal in that segment. A perfusion defect at peak
stress was considered to be an artefact if there was a suspi-
cion of a perfusion artefact, such as lateral or anterior
shadowing from ribs or lungs, or basal segments shad-
owed by contrast. In such segments, the ischaemic evalu-
ation was based on wall motion analysis alone. If wall
motion decreased at stress compared to rest images, the
segment was considered ischaemic. Since perfusion can be
decreased without a decrease in wall motion at ASE, the
use of solitary wall motion analysis in segments with per-
fusion artefacts might decrease the sensitivity with regard
to ischaemia. However, this complementary use of wall
motion analysis increases the number of interpretable seg-
ments without negatively affecting specificity [12,18]. If
there was disagreement between readers with regard to
one segment, this particular segment was re-assessed in a
joint reading until consensus was reached.
SPECT
The rest and stress studies were performed using a 2-day
protocol, starting with injection of 600 MBq 99mTc-tetro-
fosmin at stress. Stress was simultaneous with the RTP-
ASE. Normal findings at stress were not followed by a rest
study [31,32]. Pathological stress studies were followed by
a rest study with injection of 800 MBq 99mTc-tetrofosmin.
Patients who had cardiac medications, which could inter-
fere with the stress test, were informed to have their med-
ication interrupted prior to the stress test. The decision
whether to interrupt the drug administration was at the
discretion of the referring physician. A five-minute adeno-
sine infusion protocol was used. Starting the infusion
with 100 μg/ml/min of adenosine for 1 minute, the dose
was then increased to 140 μg/ml/min for two minutes
before injecting 99mTc-tetrofosmin. Infusion of adenosine
was continued for 2 min after the injection of 99mTc-tetro-
fosmin. The scintigraphic data were acquired one hour
after the end of the stress test, using continuous SPECT
over 180 degree elliptical rotation from the 45 degree
right anterior oblique position, with a dual-head gamma
camera (Siemens AG Medical Solutions, Erlangen, Ger-
many). Low energy high-resolution collimator and a
zoom factor of 1.0 were used. We obtained 64 projections
in a 128 × 128 matrix, with an acquisition time of 20 s per
projection. Tomographic reconstruction and calculation
of short axis slice images were performed using Siemens
software. A two-dimensional Butterworth pre-reconstruc-
tion filter was used with critical frequency of 0.35, order
5. For each patient, the same sets of short axis slices were
then processed with an automatic software package (4D-
MSPECT) on a Siemens e.soft workstation. The software
package defined apex and base and generated, coronal,
longitudinal, sagital tomographic slices as well as polar
maps with schematic map of the territories of the main
coronary arteries used for scoring. Radiotracer uptake of
the vascular segments were scored visually and stress
images were compared with rest images regarding ischae-
mia and infarct. The specialist in nuclear medicine who
performed the scoring was blinded to the results of the
RTP analysis.
Statistical analysis
Method of reference for the ischaemia evaluation in the
study was the presence or absence of reversible ischaemia
at the SPECT examination. Continuous variables are
expressed as mean ± 1SD and as percent. P < 0.05 denoted
significance. Receiver operating characteristic (ROC)
curves were used to examine and compare predictive abil-
ity of different parametric variables, by calculating sensi-
tivity, specificity, accuracy, positive and negative
predictive values (PPV, NPV) and area under the curve
(AUC). Unpaired t-test was used to test for difference
between patients. For intra-assay variability of quantita-
tive measurements of A and β, coefficient of variation was
used.
Results
Clinical data were retrieved form patients records. Patient
characteristics are presented in Table 1. Adenosine infu-Page 4 of 10
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and blood pressure, where heart rate increased from 72 ±
14 to 82 ± 14 (p < 0.001), systolic blood pressure
decreased from 133 ± 20 to 127 ± 20 (p < 0.001) and
pulse-pressure product increased from 9.65 ± 2.32 k to
10.44 ± 2.57 k (p < 0.001). Only minor side-effects
occurred and no stress-test had to be interrupted due to
side-effects. At SPECT 18 patients (27%) were ischaemic
with a total of 19 ischaemic territories; 10 LAD territories,
5 LCx territories and 4 RCA territories.
Of the 201 coronary distribution territories, 28 (14%)
could not be analyzed due to perfusion artefacts according
to the visual perfusion analysis. These territories were still
evaluated in the visual perfusion analysis with combined
wall motion evaluation, since wall motion still could be
analyzed in these territories. In the quantitative analysis
two more territories were considered non-interpretable
using the Qontrast® software due to low parametric image
quality, which made it too difficult to differentiate the left
ventricular myocardium from the cavity. A summary of
non-interpretable territories is presented in Table 2. In
Table 3 the different results from both quantitative and
visual interpretations are summarized. Quantitative
reserve parameters β-r and Axβ-r showed significant AUC
and kappa in all coronary territories. All quantitative
reserve parameters expressed significant kappa values in
the LAD coronary territory. Both visual analyses demon-
strated higher kappa values and accuracy than any quanti-
tative parameter.
From the ROC curves (Figure 3a-d) AUC is visualized and
levels of sensitivity at different specificity values can be
estimated. Despite the non-significant AUC for all reserve
variables in the LCx and RCA territories, there is a notable
level of sensitivity at preserved 100% specificity for β-r in
both territories, and for Axβ-r in the RCA territory. Figure
4 represents a graph of accuracy between different modal-
ities of RTP-ASE versus SPECT. When dividing the patient
population into those without and those with ischemia at
SPECT, there were significant differences for A-r, β-r and
Axβ-r in the LAD territory and for β-r in the all-territory
analysis. All variables and territory differences are given in
Table 4.
Intra-observer variability for A and β was assessed by a sec-
ond blinded reading of 10 randomly selected patients
from the study. Variability was 6.0% and 18% for A and β,
respectively. Visual inter- and intra-observer variability is
presented in Table 5.
Discussion
This agreement study indicates that Qontrast® could possi-
bly be used for quantitative measurements of myocardial
ischaemia from RTP-ASE acquired images, but only in the
LAD territory. All three quantitative parameters, A-r, β-r
and Axβ-r showed significant agreement with SPECT in
the LAD territory. Only β-r and Axβ-r showed significant
agreement with SPECT in the all-territory analysis, but in
the analyses by the specific coronary territories they only
showed significant agreement with SPECT in the LAD ter-
ritory. Qontrast® provides consistently high negative pre-
dictive values and reasonably high specificity at present
cut off values, which is of importance for ruling out
ischaemia. Sensitivity and positive predictive value could
Table 1: Patient characteristics (n = 67 unless otherwise noted).
Age 68 (± 10)
Male 33 %
LVEF at rest 54 (± 11) %
Previous AMI 40 %
Previous PCI 19 %
Previous CABG 13 %
Heart failure 13 %
Hypertension 48 %
Valvular surgery 0 %
Beta-blocker 57 %
ACE inhibitor 28 %
ARB 12 %
Nitro-glycerine (short acting) 57 %
Nitrates (long acting) 25 %
Diuretics 27 %
Calcium blocker 18 %
Sinus rhythm 93 %
Dilated left ventricle 13 %
Dilated left atrium (n = 43) 33 %
Significant valvular disease (n = 43) 7 %
Regional WMA/PD at rest 60 %
LVEF, left ventricular ejection fraction; AMI, acute myocardial 
infarction; PCI, percutaneous coronary intervention, CABG, coronary 
artery bypass grafting; ACE, angiotensin converting enzyme; ARB, 
angiotensin-receptor blocker, WMA, wall motion abnormality; PD, 
perfusion defect.
Table 2: Non interpretable coronary territories for Qontrast® quantification and visual interpretation with complementary wall 











Qontrast® (%) 30 (15) 12 (18) 16 (24) 2 (3) 15 (22)
Vis 1 (%) 0 0 0 0 0
Vis 2 (%) 28 (14) 11 (16) 16 (24) 1 (1) 22 (33)Page 5 of 10
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been more detailed, i.e. following a 17 segment model.
However, then there probably would have been a greater
anatomical mismatch between echocardiography and
SPECT. Visual evaluation of myocardial ischaemia
showed better results than automated quantification
using Qontrast®. The visual analysis using a combination
of perfusion and wall motion to increase the number of
interpretable segments, as well as the sole perfusion anal-
ysis, both showed excellent agreement with SPECT, which
has been suggested previously [10,11,33,34]. It should be
noted, however, that adenosine is a suboptimal stressor
for wall motion analysis only [3].
There are of course differences between RTP-ASE and
SPECT. The spatial resolution of echocardiography is
higher than with SPECT, which might suggest missed
minor ischaemic territories at SPECT. However, it is
known that a SPECT image without signs of ischaemia is
associated with few cardiac events [7]. Also, replenish-
ment curves are not possible to produce using SPECT
imaging, which might lead to differences between the two
methods tested in the present study. The differences could
have been partly elucidated if coronary angiography had
been performed, and the lack of such examination. Fur-
thermore, the fact that coronary angiography was not
available in these patients prohibit us from separating per-
fusion defects caused by macro-vascular or by micro-vas-
cular disease this might be considered a limitation of the
study. However, both SPECT and RTP-ASE assess myocar-
dial perfusion, whereas coronary angiography presents a
morphological image, which is the main reason why
SPECT was chosen as reference method. A major disad-
vantage of the quantitative detection of ischaemia, com-
pared with visual interpretation, is the much lower
feasibility, where the present study shows nearly 20%
non-interpretable segments using Qontrast®. Visual inter-
pretation with complementary wall motion analysis
could be performed in all of the included patients. The
study findings only apply to patient groups with sus-
pected myocardial ischaemia and, for example, not to
patient populations with acute coronary syndrome.
The results indicate that the quantification of myocardial
ischaemia is still in need of improvement to be clinically
useful, which is in line with previous studies [24,30]. The
Table 3: Results for the respective quantitative variables and visual interpretations (QV), A-reserve, (A-r), -reserve, ( -r) and 
Ax -reserve (Ax -r), visual RTP-ASE interpretation with complementary wall motion (Vis 1) and with sole perfusion interpretation 
(Vis 2).
QV Coronary Territory Acc
(%)





A All 43 39 75 11 94 NS 0.529 NS
A LAD 67 66 75 27 94 0.237 * 0.705 NS
A LCx 29 28 50 6 87 NS 0.229 NS
A RCA 32 28 100 8 100 NS 0.518 NS
All 80 83 56 25 95 0.249 *** 0.678 *
LAD 82 83 75 43 95 0.442 ** 0.773 *
β LCx 82 94 25 25 94 NS 0.590 NS
β RCA 72 74 50 11 96 NS 0.666 NS
Ax All 75 77 63 22 95 0.213 ** 0.665 *
Ax LAD 82 83 75 43 95 0.442 ** 0.818 **
Axβ LCx 90 96 25 33 94 NS 0.404 NS
Axβ RCA 58 57 75 10 97 NS 0.680 NS
A Patient wise 35 11 100 29 11 NS NA
Patient wise 60 53 79 38 87 0.233 * NA
Axβ Patient wise 47 38 73 31 79 NS NA
Vis 1 All 93 90 93 59 99 0.67 *** NA
Vis 1 LAD 87 90 86 53 98 0.59 *** NA
Vis 1 LCx 94 100 94 56 100 0.68 *** NA
Vis 1 RCA 96 75 100 100 98 0.85 *** NA
Vis 1 Patient wise 90 89 90 76 96 0.75 *** NA
Vis 2 All 92 94 92 55 99 0.67 *** NA
Vis 2 LAD 86 100 83 53 100 0.61 *** NA
Vis 2 LCx 94 100 94 57 100 0.68 *** NA
Vis 2 RCA 95 75 97 60 98 0.64 *** NA
Vis 2 Patient wise 89 91 88 71 97 0.73 *** NA
A, peak signal intensity; β, myocardial blood flow velocity; Axβ, myocardial blood flow; Acc, accuracy; Sens, sensitivity; Spec, specificity; PPV, 
positive predictive value; NPV, negative predictive value; AUC, area under the curve; * = p < 0.05; ** = p < 0.01; *** = p < 0.001; NS, not significant; 
NA, not applicable. Bold indicates significance and italics indicates not significant or not applicable.Page 6 of 10
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automatic tissue recognition. However, this is expected to
improve in the future, when both echocardiographic
image quality and the algorithms for tissue or contrast rec-
ognition are expected to improve, leading to higher signal
to noise ratio[35]. So far in echocardiography, human
brain capacity and experience seem to beat the computer
in perfusion contrast echocardiography. Still, a combina-
tion of visual and software-based analysis might be of
interest [23,36]. Moreover, the justification of the cost of
echo contrast and its real clinical additive value needs to
be conclusively proven.
Contrast safety
The U.S. Food and Drug Administration issued on Octo-
ber the 10th 2007 a "black box" warning for perflutren-
containing contrast agents, which caused considerable
controversies within the echocardiography community
[37]. This warning was later relaxed [38]. Three recent
large retrospective studies have disputed the suggestion
that using the current generation echo contrast would
pose a hazard to the patient [38-40]. Kusnetzky and co-
workers reported single-centre data on 18.671 consecutive
studies and found no increased acute mortality in patients
who had received a contrast agent [39]. Main et al.
reported data from a multicenter registry that included
4.300.966 consecutive patients [38]. Their finding was
that patients who had received echo contrast actually had
a lower mortality rate compared to those who had not
received contrast. Furthermore, Dolan et al. compared
23.659 patients from three U.S. medical centres who had
received echo contrast, at a rest examination, with 5.900
a-d. Receiver operator characteristics curves of the quantitative perfusion measurements A-, β- and Axβ- reserve in all coro-nary t rritories (a), LAD terri o y (b), LCx terri ory (c) and RCA territ ry (d), as compared with ischaemia at SPECTFigur  3
a-d. Receiver operator characteristics curves of the quantitative perfusion measurements A-, - and Ax - 
reserve in all coronary territories (a), LAD territory (b), LCx territory (c) and RCA territory (d), as compared 
with ischaemia at SPECT. LAD, left anterior descending; LCx, left circumflex; RCA, right coronary artery; A-r, peak signal 
intensity reserve; β-r, myocardial blood flow velocity reserve; Axβ-r, myocardial blood flow reserve.Page 7 of 10
(page number not for citation purposes)
Cardiovascular Ultrasound 2009, 7:28 http://www.cardiovascularultrasound.com/content/7/1/28
Page 8 of 10
(page number not for citation purposes)
A graph of accuracy between different modalities of RTP-ASE versus SPECTFi ure 4
A graph of accuracy between different modalities of RTP-ASE versus SPECT. Left anterior descending (LAD), left 
circumflex (LCx) and right coronary artery (RCA). Peak signal intensity (A), myocardial blood flow velocity (β), myocardial 
blood flow (Axβ).
Table 4: t-test for quantitative variables (QV) peak signal intensity (A), myocardial blood flow velocity ( ) and myocardial blood flow 
(Ax ) at rest, stress and their respective reserves, if no ischaemia or ischaemia at SPECT.
No Ischaemia at SPECT Ischaemia at SPECT
QV CA Rest Stress Reserve Rest Stress Reserve
A All 46.9 ± 14.6 55.7 ± 10.1 1.13 ± 0.60 44.3 ± 15.3 52.0 ± 9.6 1.33 ± 1.26
A LAD 48.7 ± 9.7 56.7 ± 11.7 1.05 ± 0.32 51.2 ± 7.9 51.3 ± 4.9 0.86 ± 0.20 *
A LCx 37.1 ± 14.1 53.8 ± 6.5 1.48 ± 0.91 26.0 ± 12.4 46.7 ± 1.3 ** 2.78 ± 2.00
A RCA 54.9 ± 13.3 56.3 ± 10.9 0.92 ± 0.28 51.5 ± 13.5 57.2 ± 17.0 0.82 ± 0.34
β All 1.12 ± 0.41 4.7 ± 3.3 2.52 ± 1.98 1.26 ± 0.38 3.2 ± 1.6 ** 1.55 ± 0.87 *
β LAD 1.15 ± 0.36 3.8 ± 1.6 1.77 ± 0.75 1.28 ± 0.25 2.7 ± 1.3 1.20 ± 0.59 *
β LCx 1.16 ± 0.47 6.4 ± 4.3 3.58 ± 2.74 1.04 ± 0.26 3.9 ± 2.3 2.39 ± 1.14
β RCA 1.04 ± 0.40 4.1 ± 2.8 2.28 ± 1.59 1.51 ± 0.64 3.4 ± 1.8 1.41 ± 0.65 *
Axβ All 55.7 ± 32.4 261 ± 18 3.54 ± 4.60 59.6 ± 31.5 172 ± 100 ** 2.87 ± 4.13
Axβ LAD 60.2 ± 26.9 222 ± 118 2.21 ± 1.38 68.0 ± 17.2 138 ± 58 ** 1.11 ± 0.71 *
Axβ LCx 47.0 ± 34.5 346 ± 235 6.20 ± 7.24 28.5 ± 16.7 187 ± 111 7.91 ± 6.18
Axβ RCA 60.2 ± 33.7 232 ± 166 2.53 ± 2.17 79.7 ± 45.8 222 ± 147 1.35 ± 0.85 *
CT, coronary territory; *, p < 0.05; **, p < 0.01 for level of significant difference between no ischaemia and ischaemia at SPECT.
Cardiovascular Ultrasound 2009, 7:28 http://www.cardiovascularultrasound.com/content/7/1/28controls who had not received contrast, and found no
increased mortality or nonfatal myocardial infarct in
patients who had received contrast [40]. Dolan and co-
workers extended their analysis and compared 10.788
patients who had undergone stress echocardiography
(DSE or exercise stress echocardiography) and received
contrast with 15.989 who had not received contrast. No
increased mortality or nonfatal myocardial infarct in
patients who had received contrast could be found also in
this cohort. These studies clearly show that using echo
contrast in stable patients does not pose a significant risk.
This knowledge must be weighted against the hazards of a
non-diagnostic echocardiography examination, and the
potential risks accompanied by alternative tests. The use
of contrast in difficult to image patients has been proven
cost effective [41], however cost effectiveness remains to
be demonstrated in the setting of RTP-ASE.
Conclusion
The results of the present agreement study indicate that
RTP-ASE Qontrast® quantification of myocardial ischae-
mia is less accurate than visual evaluation, as compared
with SPECT. At present this method cannot be recom-
mended for clinical use, but future development of
echocardiographic image quality and software properties
may improve the method.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
PG, RW, MD and RBW initiated the study. RW, MD and
OT supervised the study and participated in the interpre-
tation of the results and manuscript preparation. PG per-
formed measurements, made all data conversions, plots
and calculations from ultrasound data, and participated
in the preparation of the manuscript. PG, KS, RW and MD
participated in data collection, performed statistical anal-
ysis and participated in the interpretation of the results. LL
and RBW participated in the interpretation of the results,
in the creation of plots and in the preparation of the man-
uscript. MK participated in the interpretation of the results
and preparation of the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This study was supported by grants from University Hospital UMAS, Malmö 
and The Laerdal Foundation for Acute Medicine. We thank the personnel 
at the Department of Clinical Physiology and the Department of Cardiol-
ogy, University Hospital UMAS, Malmö for their skilful assistance with and 
in conjunction to scintigraphic and echocardiographic examinations.
References
1. Erhardt L, Herlitz J, Bossaert L, Halinen M, Keltai M, Koster R, Mar-
cassa C, Quinn T, van Weert H: Task force on the management
of chest pain.  Eur Heart J 2002, 23(15):1153-1176.
2. Cardiology TFotESo: Management of stable angina pectoris.
Recommendations of the Task Force of the European Soci-
ety of Cardiology.  Eur Heart J 1997, 18(3):394-413.
3. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P,
Poldermans D, Voigt JU, Zamorano JL: Stress echocardiography
expert consensus statement: European Association of
Echocardiography (EAE) (a registered branch of the ESC).
Eur J Echocardiogr 2008, 9(4):415-437.
4. Schinkel AF, Bax JJ, Geleijnse ML, Boersma E, Elhendy A, Roelandt JR,
Poldermans D: Noninvasive evaluation of ischaemic heart dis-
ease: myocardial perfusion imaging or stress echocardiogra-
phy?  Eur Heart J 2003, 24(9):789-800.
5. Picano E: Stress echocardiography.  Expert Rev Cardiovasc Ther
2004, 2(1):77-88.
6. Sozzi FB, Elhendy A, Roelandt JR, van Domburg RT, Schinkel AF,
Vourvouri EC, Bax JJ, Rizzello V, Poldermans D: Long-term prog-
nosis after normal dobutamine stress echocardiography.  Am
J Cardiol 2003, 92(11):1267-1270.
7. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Har-
binson M, Kelion AD, Al-Mohammad A, Prvulovich EM, Shaw LJ, et al.:
Myocardial perfusion scintigraphy: the evidence.  Eur J Nucl
Med Mol Imaging 2004, 31(2):261-291.
8. Lafitte S, Matsugata H, Peters B, Togni M, Strachan M, Kwan OL,
DeMaria AN: Comparative value of dobutamine and adenos-
ine stress in the detection of coronary stenosis with myocar-
dial contrast echocardiography.  Circulation 2001,
103(22):2724-2730.
9. Takeishi Y, Chiba J, Abe S, Ikeda K, Tomoike H: Adenosine-
echocardiography for the detection of coronary artery dis-
ease.  J Cardiol 1994, 24(1):1-7.
10. Mor-Avi V, Caiani EG, Collins KA, Korcarz CE, Bednarz JE, Lang RM:
Combined assessment of myocardial perfusion and regional
left ventricular function by analysis of contrast-enhanced
power modulation images.  Circulation 2001, 104(3):352-357.
11. Gudmundsson P, Winter R, Dencker M, Kitlinski M, Thorsson O,
Ljunggren L, Willenheimer R: Real-time perfusion adenosine
stress echocardiography versus myocardial perfusion adeno-
sine scintigraphy for the detection of myocardial ischaemia
in patients with stable coronary artery disease.  Clin Physiol
Funct Imaging 2006, 26(1):32-38.
12. Winter R, Gudmundsson P, Willenheimer R: Real-time perfusion
adenosine stress echocardiography in the coronary care
unit: a feasible bedside tool for predicting coronary artery
stenosis in patients with acute coronary syndrome.  Eur J
Echocardiogr 2005, 6(1):31-40.
13. Mulvagh SL: Advances in myocardial contrast echocardiogra-
phy and the role of adenosine stress.  Am J Cardiol 2004,
94(2A):12D-17D.
14. Jeetley P, Hickman M, Kamp O, Lang RM, Thomas JD, Vannan MA,
Vanoverschelde JL, Wouw PA van der, Senior R: Myocardial con-
trast echocardiography for the detection of coronary artery
stenosis: a prospective multicenter study in comparison with
single-photon emission computed tomography.  J Am Coll Car-
diol 2006, 47(1):141-145.
15. Korosoglou G, Dubart AE, DaSilva KG Jr, Labadze N, Hardt S, Hansen
A, Bekeredjian R, Zugck C, Zehelein J, Katus HA, et al.: Real-time
myocardial perfusion imaging for pharmacologic stress test-
ing: added value to single photon emission computed tomog-
raphy.  Am Heart J 2006, 151(1):131-138.
16. Tsutsui JM, Xie F, McGrain AC, Mahrous H, Hankins J, O'Leary EL,
Porter TR: Comparison of low-mechanical index pulse
sequence schemes for detecting myocardial perfusion
abnormalities during vasodilator stress echocardiography.
Am J Cardiol 2005, 95(5):565-570.
Table 5: Agreement of visual myocardial contrast 
echocardiography ischaemia interpretation (n = 33).





















LAD, Left anterior descending coronary artery; LCx, Left Circumflex 
artery; RCA, Right posterior descending coronary artery; **, p < 0.01; 
***, p < 0.001, NS, not significant.Page 9 of 10
(page number not for citation purposes)
Cardiovascular Ultrasound 2009, 7:28 http://www.cardiovascularultrasound.com/content/7/1/28Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
17. Wasmeier GH, Asmussen S, Voigt JU, Flachskampf FA, Daniel WG,
Nixdorff U: Real-time myocardial contrast stress echocardi-
ography using bolus application.  Ultrasound Med Biol 2008,
34(11):1724-1731.
18. Gudmundsson P, Shahgaldi K, Winter R, Dencker M, Kitlinski M,
Thorsson O, Ljunggren L, Willenheimer R: Head to head compar-
isons of two modalities of perfusion adenosine stress
echocardiography with simultaneous SPECT.  Cardiovasc Ultra-
sound 2009, 7:19.
19. Lafitte S, Higashiyama A, Masugata H, Peters B, Strachan M, Kwan OL,
DeMaria AN: Contrast echocardiography can assess risk area
and infarct size during coronary occlusion and reperfusion:
experimental validation.  J Am Coll Cardiol 2002, 39(9):1546-1554.
20. Agati L, Tonti G, Pedrizzetti G, Magri F, Funaro S, Madonna M, Celani
F, Messager T, Broillet A: Clinical application of quantitative
analysis in real-time MCE.  Eur J Echocardiogr 2004, 5(Suppl
2):S17-23.
21. Bekeredjian R, Hilbel T, Filusch A, Hansen A, Benz A, Zehelein J,
Kuecherer HF: Fourier phase and amplitude analysis for auto-
mated objective evaluation of myocardial contrast echocar-
diograms.  Int J Cardiovasc Imaging 2003, 19(2):117-128.
22. Peltier M, Vancraeynest D, Pasquet A, Ay T, Roelants V, D'Hondt AM,
Melin JA, Vanoverschelde JL: Assessment of the physiologic sig-
nificance of coronary disease with dipyridamole real-time
myocardial contrast echocardiography. Comparison with
technetium-99m sestamibi single-photon emission com-
puted tomography and quantitative coronary angiography.  J
Am Coll Cardiol 2004, 43(2):257-264.
23. Korosoglou G, da Silva KG Jr, Labadze N, Dubart AE, Hansen A,
Rosenberg M, Zehelein J, Kuecherer H: Real-time myocardial
contrast echocardiography for pharmacologic stress testing:
is quantitative estimation of myocardial blood flow reserve
necessary?  J Am Soc Echocardiogr 2004, 17(1):1-9.
24. Malm S, Frigstad S, Torp H, Wiseth R, Skjarpe T: Quantitative ade-
nosine real-time myocardial contrast echocardiography for
detection of angiographically significant coronary artery dis-
ease.  J Am Soc Echocardiogr 2006, 19(4):365-372.
25. Bierig SM, Mikolajczak P, Herrmann SC, Elmore N, Kern M, Labovitz
AJ: Comparison of myocardial contrast echocardiography
derived myocardial perfusion reserve with invasive determi-
nation of coronary flow reserve.  Eur J Echocardiogr 2008.
26. Agati L, Tonti G, Galiuto L, Di Bello V, Funaro S, Madonna MP, Gar-
ramone B, Magri F: Quantification methods in contrast
echocardiography.  Eur J Echocardiogr 2005, 6(Suppl 2):S14-20.
27. Becher H, Burns P: Handbook of Contrast Echocardiography.
Left ventricular function and myocardial perfusion.  Frankfurt
and New York: Springer Verlag; 2000. 
28. Bahlmann EB, McQuillan BM, Handschumacher MD, Chow CM,
Guerrero JL, Picard MH, Weyman AE, Scherrer-Crosbie M: Effect of
destructive pulse duration on the detection of myocardial
perfusion in myocardial contrast echocardiography: In vitro
and in vivo observations.  J Am Soc Echocardiogr 2002,
15(12):1440-1447.
29. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S: Quan-
tification of myocardial blood flow with ultrasound-induced
destruction of microbubbles administered as a constant
venous infusion.  Circulation 1998, 97(5):473-483.
30. Moir S, Haluska BA, Jenkins C, McNab D, Marwick TH: Myocardial
blood volume and perfusion reserve responses to combined
dipyridamole and exercise stress: a quantitative approach to
contrast stress echocardiography.  J Am Soc Echocardiogr 2005,
18(11):1187-1193.
31. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J,
Bengel F, Busemann Sokole E, Davies G, Dondi M, et al.: EANM/ESC
procedural guidelines for myocardial perfusion imaging in
nuclear cardiology.  Eur J Nucl Med Mol Imaging 2005,
32(7):855-897.
32. Henzlova MJ, Cerqueira MD, Mahmarian JJ, Yao SS: Stress proto-
cols and tracers.  J Nucl Cardiol 2006, 13(6):e80-90.
33. Sieswerda GT, Yang L, Boo MB, Kamp O: Real-time perfusion
imaging: a new echocardiographic technique for simultane-
ous evaluation of myocardial perfusion and contraction.
Echocardiography 2003, 20(6):545-555.
34. Olszowska M, Kostkiewicz M, Tracz W, Przewlocki T: Assessment
of myocardial perfusion in patients with coronary artery dis-
ease. Comparison of myocardial contrast echocardiography
and 99mTc MIBI single photon emission computed tomog-
raphy.  Int J Cardiol 2003, 90(1):49-55.
35. Yoshifuku S, Chen S, McMahon E, Korinek J, Yoshikawa A, Ochiai I,
Sengupta PP, Belohlavek M: Parametric detection and measure-
ment of perfusion defects in attenuated contrast echocardi-
ographic images.  J Ultrasound Med 2007, 26(6):739-748.
36. Yu EH, Skyba DM, Leong-Poi H, Sloggett C, Jamorski M, Garg R, Iwan-
ochko RM, Siu SC: Incremental value of parametric quantita-
tive assessment of myocardial perfusion by triggered Low-
Power myocardial contrast echocardiography.  J Am Coll Car-
diol 2004, 43(10):1807-1813.
37. Main ML, Goldman JH, Grayburn PA: Thinking outside the "box"-
the ultrasound contrast controversy.  J Am Coll Cardiol 2007,
50(25):2434-2437.
38. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M:
Acute mortality in hospitalized patients undergoing
echocardiography with and without an ultrasound contrast
agent (multicenter registry results in 4,300,966 consecutive
patients).  Am J Cardiol 2008, 102(12):1742-1746.
39. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML:
Acute mortality in hospitalized patients undergoing
echocardiography with and without an ultrasound contrast
agent: results in 18,671 consecutive studies.  J Am Coll Cardiol
2008, 51(17):1704-1706.
40. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D,
Bierig M, Mulvagh SL, Porter TR, Labovitz AJ: Safety and efficacy of
commercially available ultrasound contrast agents for rest
and stress echocardiography a multicenter experience.  J Am
Coll Cardiol 2009, 53(1):32-38.
41. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H,
Bierig SM, Burns PN, Castello R, Coon PD, Hagen ME, et al.: Amer-
ican Society of Echocardiography Consensus Statement on
the Clinical Applications of Ultrasonic Contrast Agents in
Echocardiography.  J Am Soc Echocardiogr 2008, 21(11):1179-1201.Page 10 of 10
(page number not for citation purposes)
